JP2010510994A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510994A5
JP2010510994A5 JP2009538564A JP2009538564A JP2010510994A5 JP 2010510994 A5 JP2010510994 A5 JP 2010510994A5 JP 2009538564 A JP2009538564 A JP 2009538564A JP 2009538564 A JP2009538564 A JP 2009538564A JP 2010510994 A5 JP2010510994 A5 JP 2010510994A5
Authority
JP
Japan
Prior art keywords
peptide
seq
immunogenic composition
composition
based immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009538564A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510994A (ja
JP5177451B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2007/002164 external-priority patent/WO2008064488A1/en
Publication of JP2010510994A publication Critical patent/JP2010510994A/ja
Publication of JP2010510994A5 publication Critical patent/JP2010510994A5/ja
Application granted granted Critical
Publication of JP5177451B2 publication Critical patent/JP5177451B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009538564A 2006-11-30 2007-11-30 インフルエンザワクチン製剤 Expired - Fee Related JP5177451B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86800806P 2006-11-30 2006-11-30
US60/868,008 2006-11-30
PCT/CA2007/002164 WO2008064488A1 (en) 2006-11-30 2007-11-30 Influenza vaccine formulation

Publications (3)

Publication Number Publication Date
JP2010510994A JP2010510994A (ja) 2010-04-08
JP2010510994A5 true JP2010510994A5 (enExample) 2011-01-27
JP5177451B2 JP5177451B2 (ja) 2013-04-03

Family

ID=39467397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009538564A Expired - Fee Related JP5177451B2 (ja) 2006-11-30 2007-11-30 インフルエンザワクチン製剤

Country Status (6)

Country Link
US (2) US7807173B2 (enExample)
EP (1) EP2097103B1 (enExample)
JP (1) JP5177451B2 (enExample)
CN (1) CN101622009B (enExample)
CA (1) CA2670965C (enExample)
WO (1) WO2008064488A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2097103B1 (en) * 2006-11-30 2012-10-03 Variation Biotechnologies Inc. Influenza vaccine formulation
KR101701198B1 (ko) 2008-06-19 2017-02-01 배리에이션 바이오테크놀로지스 아이엔씨. 인플루엔자를 치료하기 위한 조성물 및 방법
WO2011138032A2 (en) * 2010-05-05 2011-11-10 Artemev, Timur Universal influenza vaccines and methods for their generation
US20140328876A1 (en) 2011-11-18 2014-11-06 Variation Biotechnologies Inc. Synthetic derivatives of mpl and uses thereof
EP3337822A1 (en) 2015-08-19 2018-06-27 Rutgers, The State University of New Jersey Novel methods of generating antibodies
DK3516064T3 (da) 2016-09-20 2025-07-14 Boehringer Ingelheim Vetmedica Gmbh Nye promotorer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118874B2 (en) 1998-10-09 2006-10-10 Variation Biotechnologies Inc. Immunogenic formulation and process for preparation thereof
US6896881B1 (en) * 1999-09-24 2005-05-24 Mayo Foundation For Medical Education And Research Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
CN1163271C (zh) * 2000-08-10 2004-08-25 清华大学 一种合成肽流感疫苗的制备方法
ATE533113T1 (de) * 2002-02-08 2011-11-15 Variation Biotechnologies Inc Verfahren zur herstellung von immunogenen zusammensetzungen aus variablen peptidepitopen
BRPI0407877A (pt) 2003-03-07 2006-03-01 Merck & Co Inc conjugado de peptìdeo-proteìna, vacina para a prevenção ou melhora da infecção pelo vìrus influenza, e, método para induzir um resposta imune em um paciente
US20090104216A1 (en) * 2005-06-01 2009-04-23 Variation Biotechnologies, Inc. Peptide-Based Influenza Vaccine Formulation
CA2627105A1 (en) * 2005-10-26 2007-05-03 Protelix, Inc. Influenza combinatorial antigen vaccine
AU2006311752A1 (en) 2005-11-07 2007-05-18 Sidney Kimmel Cancer Center CD40 ligand fusion protein vaccine
WO2008112017A2 (en) * 2006-10-10 2008-09-18 The Government Of The United States Of America, As Represented By The Secretary, Department Of Healtand Human Services Avian influenza vaccine
EP2097103B1 (en) * 2006-11-30 2012-10-03 Variation Biotechnologies Inc. Influenza vaccine formulation

Similar Documents

Publication Publication Date Title
JP2010534684A5 (enExample)
JP2006006329A5 (enExample)
NO2023048I1 (en) A composition comprising: cedazuridine or a pharmaceutically acceptable salt thereof, and decitabine
JP2009524695A5 (enExample)
JP2006213929A5 (enExample)
JP2010065037A5 (enExample)
JP2011526809A5 (enExample)
JP2013510581A5 (enExample)
JP2007169302A5 (enExample)
JP2009533064A5 (enExample)
JP2010088434A5 (enExample)
JP2009504138A5 (enExample)
JP2009520682A5 (enExample)
JP2008519810A5 (enExample)
JP2008545719A5 (enExample)
JP2009509934A5 (enExample)
JP2007508806A5 (enExample)
JP2009507965A5 (enExample)
DA Watanabe
JP2005531640A5 (enExample)
JP2008545704A5 (enExample)
Nirala Kullibhat
Adams The history of Japan; v. 1
甘文胜 Do I Know You?
Rayejian Asli Restorative justice